3-2 biosafety risk management
TRANSCRIPT
-
7/31/2019 3-2 Biosafety Risk Management
1/87
BIOSAFETY RISKMANAGEMENT
-
7/31/2019 3-2 Biosafety Risk Management
2/87
Design and operation of a bioprocessing facility
must assure safety of personnel within the facility
and those in the surrounding community
Protection is achieved through a combination of
engineered facilities, processes, and equipment
worker training and education
use of personnel protective equipment
operational practices
validation of machinery and methodologies controlled access to facilities
biosafety committee or subcommittee
medical and environmental surveillance
-
7/31/2019 3-2 Biosafety Risk Management
3/87
Activities involving LMO are regulated by the
Biosafety Act 2007and Biosafety Regulations
2010, to ensure safe application of
biotechnology in a responsible and orderly
manner.
-
7/31/2019 3-2 Biosafety Risk Management
4/87
BIOSAFETY LEVELS (BSL) FOR
CONTAINMENT
-
7/31/2019 3-2 Biosafety Risk Management
5/87
Biosafety containment of the LMO activity is
achieved with a combination of facility design,
administrative controls, engineering controls or
use of Personal Protective Equipment (PPE).
There are four BSL for containment based on
existing international approaches to
pathogenic organisms:
Biosafety Level 1 (BSL1)
Biosafety Level 2 (BSL2)
Biosafety Level 3 (BSL3)
Biosafety Level 4 (BSL4)
-
7/31/2019 3-2 Biosafety Risk Management
6/87
For genetic modification activities, five
categories of containment facility are:
Genetic Modification of Microorganisms (GM-BSL)
Genetic Modification of Plants (GP-BSL)
Genetic Modification of Animals (GA-BSL)
Genetic Modification of Arthropods (GI-BSL)
Genetic Modification of Aquatic Organisms (GF-BSL)
The genetic modification BSL dictates theminimum level of containment required for
carrying out activities with LMO and related
materials originating from these organisms.
-
7/31/2019 3-2 Biosafety Risk Management
7/87
If researchers are unsure about the
containment level required for their research
and development activities, they should
consult their respective Institutional Biosafety
Committees (IBC).
The containment requirements for work with
genetically modified (GM) microorganisms are
also the fundamental requirement forcontainment involving plants, animals,
arthropods and other aquatic organisms.
-
7/31/2019 3-2 Biosafety Risk Management
8/87
BIOSAFETY LEVEL
GUIDELINE
LaboratoryFacilities
-
7/31/2019 3-2 Biosafety Risk Management
9/87
Biosafety Level 1 (BSL-1)
Risk Group 1
Low individual and community risk (BSL1 )
Pathogenity Features
A microorganism that is unlikely to cause human
disease or animal disease.
Agents include Bacillus subtilis,non-pathogenic E. colispecies
-
7/31/2019 3-2 Biosafety Risk Management
10/87
BSL1-General
A laboratory classified as GM-BSL1 is appropriate for
conducting activities of no known or minimal
potential hazard to laboratory personnel,
community and environment as listed below:
Research involving the introduction of naked
nucleic acids into RG 1 microorganisms
Experiments with LMO microorganisms and
materials originating from these organisms Experiments involving approved host/vector
systems provided
-
7/31/2019 3-2 Biosafety Risk Management
11/87
BSL1-Laboratory Facility
a) The laboratory is not separated from the generaltraffic patterns in the building
b) The laboratory is designed with open bencheswhich can be cleaned easily
c) Bench tops should be impervious to water andresistant to acids, alkali, organic solvents and
moderate heat
d) Laboratory furniture should be sturdy. Spacebetween benches, cabinets and equipment areaccessible for cleaning
-
7/31/2019 3-2 Biosafety Risk Management
12/87
BSL1-Laboratory Facility
e) Entrances to the laboratory should be posted with an
appropriate signage identifying the type of laboratory
facility and listing the procedures applicable, including
emergency and maintenance procedures. The contact
information of the laboratory supervisor or other
responsible persons should be listed
f) Each laboratory should contain a sink for hand-washing
g) The laboratory may be equipped with fumehood
h) There should be access to a steam steriliser/autoclave
in the same building
-
7/31/2019 3-2 Biosafety Risk Management
13/87
BSL1-Work Practices
a) Laboratory personnel working in a GM-BSL1 laboratory
should be supervised by a scientist with general training
in microbiology, molecular biology or a related science.
b) Laboratory coats should be worn during work and
removed before leaving the laboratory premises. Personnel
may be required to change into footwear specified for the
laboratory. Gloves should be worn when handling LMO
and material originated from these organisms.
c) All persons handling LMO and materials originated from
these organisms should wash their hands after removing
gloves and before leaving the laboratory.
-
7/31/2019 3-2 Biosafety Risk Management
14/87
BSL1-Work Practices
d) Protective eye wear should be worn for anticipatedsplashes of microorganisms or other hazardousmaterials to the face.
e) All cultures should be clearly labelled and acentral logbook kept in the laboratory.
f) When experiments are in progress, access to thelaboratory should be limited at the discretion of the
Laboratory Supervisor.
g) Work surfaces should be decontaminated regularlyand immediately after any spill of viable material.
-
7/31/2019 3-2 Biosafety Risk Management
15/87
BSL1-Work Practices
h) All contaminated liquid or solid wastes should bedecontaminated before disposal.
i) Mechanical pipetting devices should be used,mouth pipetting is prohibited.
j) All procedures, involving liquids, are performedcarefully to minimise the creation of aerosols.
k) Eating, drinking, smoking, handling contactlenses and applying cosmetics is prohibited inlaboratories.
-
7/31/2019 3-2 Biosafety Risk Management
16/87
BSL1-Work Practices
l) Food or drinks for personal consumption should
not be brought into the laboratory or stored in
laboratory refrigerators.
m) An insect and rodent control programme should
be implemented.
-
7/31/2019 3-2 Biosafety Risk Management
17/87
The minimum PPE required for the BSL-1 laboratory
-
7/31/2019 3-2 Biosafety Risk Management
18/87
Biosafety Level 2 (BSL-2)
Risk Group 2
Moderate individual risk, limited community, livestockor environment risk (BSL2)
Pathogenicity Features
A pathogen that can cause human or animal disease butis unlikely to be a serious hazard to laboratory workers,the community, livestock or the environment
Laboratory exposure may cause serious infection.Infectious risk is via direct contact, ingestion or
inhalation. Effective treatment, preventive and control measures are
readily available and can be implemented to controldisease transmission.
Risk of spread to a community is limited.
-
7/31/2019 3-2 Biosafety Risk Management
19/87
Biosafety Level 2 (BSL-2)
Agents associated with human disease
Generally required for working with any human-derived blood, bodily fluids, tissues in which
infectious agent may be unknown
Agents include measles virus,
Salmonellaspecies, pathogenicToxoplasma, Clostridiumbotulinum, hepatitis B virus
-
7/31/2019 3-2 Biosafety Risk Management
20/87
BSL2-General
A laboratory classified as GM-BSL2 is
appropriate for conducting activities that has
moderate potential hazard to personnel,
community and the environment listed
below: Research involving the introduction of naked nucleic
acids into RG 2 microorganisms
Experiments with LMO and related materials,
harboring DNA from a RG 2 microorganism.
-
7/31/2019 3-2 Biosafety Risk Management
21/87
BSL2-Laboratory Facility
In addition to the facility design features specified for
BSL1, following additional features are essential:
a) A hazard warning sign incorporating the universal
biohazard symbol and the level of containmenttogether with access restrictions should be displayed
on the access door to the laboratory work area.
-
7/31/2019 3-2 Biosafety Risk Management
22/87
BSL2-Laboratory Facility
Example ofbiosafety signposted outside lab
working withinfectious agents
Labs biosafety level
Infectious agents
under study
Contact informationfor responsible personand 2 emergency
contacts
-
7/31/2019 3-2 Biosafety Risk Management
23/87
BSL2-Laboratory Facility
b) The ceilings, walls and floors of the laboratory
should be smooth, easy to clean, impermeable to
liquids, and resistant to commonly used reagents
and disinfectants.
c) A dedicated hand basin of the hands-free
operation type should be provided within each
laboratory, near each exit.
-
7/31/2019 3-2 Biosafety Risk Management
24/87
BSL2-Laboratory Facility
Hand basin facility
-
7/31/2019 3-2 Biosafety Risk Management
25/87
-
7/31/2019 3-2 Biosafety Risk Management
26/87
BSL2-Laboratory Facility
d) Windows in the laboratory should be closed and sealed.
e) An autoclave should be located within the building.
Autoclaves should be certified annually by the Departmentof Occupational Safety and Health/DOSH.
f) Freezers, refrigerators or other storage units used for
BSL2 microorganisms located outside the designated
laboratory should be posted with the appropriate signage.
-
7/31/2019 3-2 Biosafety Risk Management
27/87
BSL2-Laboratory ventilation
The laboratory should be well ventilated.
If required an inward flow of air should be
maintained by extracting room air using
mechanical ventilation to ensure directional
airflow.
-
7/31/2019 3-2 Biosafety Risk Management
28/87
BSL2-Work Practices
In addition to the work practices described in BSL1, the
following work practices should be observed:
a) The Laboratory Supervisor establishes policies and
procedures whereby access is restricted to persons whohave been advised of the potential hazard and who meet
specific entry requirements (e.g. immunisation).
b) Laboratory personnel should receive appropriate
training on the potential hazards associated with the workinvolved and the necessary precautions to preventexposures. Personnel should receive annual updates, or
additional training as necessary for procedural or policy
changes.
-
7/31/2019 3-2 Biosafety Risk Management
29/87
BSL2-Work Practices
c) Procedures which produce infectious aerosols
should be conducted in biological safety cabinets or
other physical containment equipment.
d) Experiments of lesser biohazard potential can becarried out concurrently in carefully demarcated
areas of the same laboratory.
e) An institutional biosafety manual is prepared oradopted for use in the laboratories. Personnel are
advised on special hazards and are required to read
and follow the instructions on practices and
procedures.
-
7/31/2019 3-2 Biosafety Risk Management
30/87
BSL2-Work Practices
f) Goggles, mask or face shield should be used for
anticipated splashes or sprays of infectious LMO and
materials originated from these materials to the face,
when handling microorganism outside the biological
safety cabinet.
g) Respiratory protection should be worn when
aerosols cannot be safely contained.
h) All solid wastes from GM-BSL2 laboratories,
including infectious waste should be decontaminated
by autoclaving for at least 30 minutes at a pressure
of 15 psi and 121oC.
-
7/31/2019 3-2 Biosafety Risk Management
31/87
BSL2-Work Practices
i) Liquid wastes generated during BSL2 activities are to bedecontaminated immediately by mixing with a suitabledisinfectant
j) Extreme caution should be observed when handlingneedles and syringes to avoid accidental needle-stickinjury and generation of aerosols during use and disposal.
k) Spills and accidents that may cause over-exposure toLMO and materials originating from these organismsshould be immediately reported to the LaboratorySupervisor and the IBC
l) A record book should be maintained to provide an up-to-date inventory of the procedures performed.
-
7/31/2019 3-2 Biosafety Risk Management
32/87
Biosafety Level 3 (BSL-3)
Risk Group 3
High individual, low community risk
Pathogenicity Features
Organism, which may be an exotic or indigenous
agent with potential to transmit disease mainly via
aerosols. Disease caused is severe and may result in
death. It could present a risk if spread in thecommunity however effective treatment, preventive
and control measures are available
-
7/31/2019 3-2 Biosafety Risk Management
33/87
Biosafety Level 3 (BSL-3)
Agents include Mycobacteriumtuberculosis,St. Louis encephalitisvirus, Francisella tularensis,Coxiella burnetii
-
7/31/2019 3-2 Biosafety Risk Management
34/87
BSL3-General
A laboratory classified as BSL3 is appropriate for
conducting activitiesthat has moderate potential
hazard to personnel, community and the
environment listed below:
Research involving the introduction of naked
nucleic acids into RG 3 microorganisms
Experiments with LMO and related materials,
harboring DNA from a RG 3 microorganism
-
7/31/2019 3-2 Biosafety Risk Management
35/87
BSL3- Laboratory Facility
The design, construction and major changes to the
GM-BSL3 facility should be certified by a
competent authority/organisation endorsed by the
NBB before commencement of work.
In addition to the facility design features specifiedfor BSL1 and BSL2, following additional features
are essential:
a) The laboratory should be physically separated
from other areas including offices used by laboratory
personnel and is not accessible by the general
public.
-
7/31/2019 3-2 Biosafety Risk Management
36/87
BSL3- Laboratory Facility
b) Physical separation of the high containment
laboratory from access corridors or other laboratories
or activities is achieved by a double door system
where entry to the laboratory facility is gainedthrough an airlock.
c) The laboratory and airlock should be sealable to
permit safe decontamination with gases.
d) All room penetrations should be sealed to ensure
they are air tight
-
7/31/2019 3-2 Biosafety Risk Management
37/87
BSL3- Laboratory Facility
e) Access doors to the laboratory or containment
module should be self-closing and open outwards.
f) One side of the laboratory wall should have a glasspanel or observation window to view laboratory
occupants from the outside.
g) An autoclave for decontaminating laboratory wasteshould be available within the laboratory, preferably
located within the barrier wall of the GM-BSL3
laboratory, but not situated in the airlock.
-
7/31/2019 3-2 Biosafety Risk Management
38/87
BSL3- Laboratory Facility
h) Liquid effluents should be discharged in a mannerappropriate to the type of waste.
i) A telephone and fax machine or other means of outside
communication should be provided inside the laboratoryunit.
j) An audible emergency alarm should be provided withinthe laboratory to indicate a loss of negative pressure and a
visible alarm is provided outside the laboratory to indicatethe same.
k) The BSL3 facility should be tested and certifiedannually at least every 12 months.
-
7/31/2019 3-2 Biosafety Risk Management
39/87
BSL3- Laboratory ventilation
The laboratory ventilation should incorporate thefollowing features:
a) A ducted exhaust air-ventilation system is
provided
b) Air supply and exhaust from Class II biologicalsafety cabinets should be connected in a mannerthat avoids any interference with the air balance of
the cabinets or buildings exhaust system.
c) The proper directional airflow into the laboratory isverified by airflow tests.
-
7/31/2019 3-2 Biosafety Risk Management
40/87
-
7/31/2019 3-2 Biosafety Risk Management
41/87
Wash hands
after removing
PPE at the
hands-free sink
-
7/31/2019 3-2 Biosafety Risk Management
42/87
Eye/face wash: understand how to use, flush at
least weekly, and identify closest station outside the
BSL-3 lab (in event of release outside ofcontainment)
-
7/31/2019 3-2 Biosafety Risk Management
43/87
BSL3- Work Practices
In addition to the work practices described in BSL1
and BSL2, the following work practices should be
observed:
a) The laboratory senior management is required toestablish policies and procedures whereby access to
the laboratory is restricted to authorised persons
who have been advised of the biohazard and who
meet any medical requirements.
b) All personnel should have specific training in
handling pathogenic organisms and in the use of
safety equipment and controls.
-
7/31/2019 3-2 Biosafety Risk Management
44/87
BSL3- Work Practices
c) The laboratory door should be locked when the
room is unoccupied.
d) If experiments involving other organisms thatrequire lower levels of containment are to be
conducted in the same laboratory concurrently with
work requiring BSL3 level physical containment,
such experiments should be conducted in
accordance with all BSL3 level practices.
-
7/31/2019 3-2 Biosafety Risk Management
45/87
BSL3- Work Practices
e) Work surfaces of biological safety cabinets andother containment equipment should bedecontaminated
f) PPE that protects street clothing (e.g. tyvex suitand boots). In addition, appropriate respiratoryprotection should be made available.
g) Liquid wastes generated during BSL3 activitiesshould be decontaminated immediately with suitabledisinfectant. All solid wastes are decontaminated byautoclaving before disposal for incineration by agovernment authorised service provider
-
7/31/2019 3-2 Biosafety Risk Management
46/87
-
7/31/2019 3-2 Biosafety Risk Management
47/87
BSL3- Work Practices
i) A medical surveillance programme should be
instituted for all persons entering a BSL3 facility
j) An Emergency Response Plan should bedocumented and personnel should be trained in
these procedures which include spill management,
emergency evacuation if necessary, as well as
incident reporting system.
-
7/31/2019 3-2 Biosafety Risk Management
48/87
Biosafety Level 4 (BSL-4)
Risk Group 4
High individual and community risk (BSL4)
Pathogenicity Features
Organism, which may be an exotic agent or new
agent usually able to cause life-threatening human
disease. The infectious disease is readily
transmissible from one individual to another.
Infectious disease may be transmitted via aerosol orvia an unknown route. Effective treatment,
preventive and control measures are not readily
available.
-
7/31/2019 3-2 Biosafety Risk Management
49/87
Biosafety Level 4 (BSL-4)
Agents (all viruses) include
Marburg virus, Ebola virus,viruses that cause Congo-Crimean hemorrhagic fever,Lassa fever
(transmission electron micrograph
of Ebola virus)
-
7/31/2019 3-2 Biosafety Risk Management
50/87
BSL4-General
A laboratory classified as BSL2 is appropriate
for conducting activities that may cause
serious harm to the laboratory personnel,
community and environment if accidentally
released listed below:
Research involving the introduction of naked nucleic
acids into RG 4 or exotic agents
Experiments with LMO and related materials,harboring DNA from a RG 4 microorganism
-
7/31/2019 3-2 Biosafety Risk Management
51/87
BSL4- Laboratory Facility
The design, construction and major changes to the BSL4
facility should be certified by a competent
authority/organisation endorsed by the NBB before
commencement of work.
In addition to the facility design features specified for
BSL1, BSL2 and BSL3 the following additional features
are essential:
a) A BSL4 facility is housed in a separate building. Anouter and inner change-room separated by a walk-throughdouble door shower airlock should be provided for
personnel entering and leaving the facility. The outer door
of the facility should be lockable.
-
7/31/2019 3-2 Biosafety Risk Management
52/87
BSL4- Laboratory Facility
b) Fumigation chamber or ventilated air-lock is
provided for passage of materials, supplies or
equipment that is not brought into the facility
through the change room.
c) As much valve and control equipment as possible
should be located outside the laboratory boundary to
minimise the need for service personnel to enter the
laboratory.
-
7/31/2019 3-2 Biosafety Risk Management
53/87
BSL4- Laboratory Facility
d) Walls, floors and ceilings of the facility should beconstructed to form a sealed internal shell that facilitatesfumigation and is animal and insect-proof. The internalsurfaces of this shell should be resistant to liquids and
chemicals, thus facilitating cleaning and decontaminationof the area. All penetrations in these structures andsurfaces should be sealed.
e) If there is a central vacuum system, it should not serveareas outside the facility. In-line HEPA filters should be
placed as near as practicable to each point of use. Filtersare installed to permit in-place decontamination andreplacement. Other liquid and gas services to the facilityare protected by devices that prevent backflow.
-
7/31/2019 3-2 Biosafety Risk Management
54/87
BSL4- Laboratory Facility
f) A double-door autoclave is provided fordecontaminating materials from the facility and fromthe inner clothing change room.
g) A pass through dunk tank or decontaminationchamber should be provided so that materials thatcannot be autoclaved can be rendered safe forremoval from the facility.
h) An automatic changeover emergency powersource, emergency lighting and communicationsystem should be provided to ensure continuingoperation of the ventilation systems, biological safetycabinets, room access and controls.
-
7/31/2019 3-2 Biosafety Risk Management
55/87
BSL4- Laboratory Facility
i) For certain requirements,
i) A specially designed suit area may be provided
within the facility.
ii) Personnel who enter this area should wear a one-piece positive pressure suit that is ventilated by a
life support system that includes an alarm and
emergency back-up breathing air system.
iii) Entry should be via an airlock fitted with a personal
body shower into an anteroom leading to a secondairlock fitted with a chemical disinfectant shower
provided to decontaminate the surface of the suit
before the personnel leaves the area.
-
7/31/2019 3-2 Biosafety Risk Management
56/87
BSL4- Laboratory Facility
i) A double door autoclave with doors at each end isprovided for decontaminating waste materials to beremoved from the suit area.
ii) An air supply for connection to the positivepressure suit should be provided in the anteroom.
iii) The exhaust air should be filtered through two setsof HEPA filters installed in series.
iv) The air pressure within the suit area should belower than that of the adjacent entry, exit and non-suit areas.
v) A duplicate ventilation system, exhaust fan and anautomatically-starting emergency power sourceshould be provided to automatically re-establishlaboratory ventilation and pressure conditions inevent of equipment failure.
-
7/31/2019 3-2 Biosafety Risk Management
57/87
BSL4- Laboratory Ventilation
The laboratory ventilation should have thefollowing features:
a) A separate supply and exhaust non re-circulating
air ventilation system should be provided.
b) Both supply and exhaust air should be filteredthrough HEPA filters.
c) The filtered air from Class III biological safetycabinets is discharged through the facility exhaustsystem in a manner that avoids any interference withthe air balance of the cabinets or the facility exhaustair system.
-
7/31/2019 3-2 Biosafety Risk Management
58/87
BSL4- Laboratory Ventilation
d) The ventilation control system should raise an
audible alarm within the laboratory and at an
attended location when room differential air
pressures depart from set points.
-
7/31/2019 3-2 Biosafety Risk Management
59/87
BSL4-Work Practices
In addition to the work practices described in BSL1,BSL2 and BSL3, the following work practices should
be observed:
a) Accessibility is managed by the LaboratorySupervisor, Biological Safety Officer (BSO) or other
persons responsible for the physical security of the
facility.
b) A facility operations manual and SOP should be
prepared by the management. Practical and effective
protocols for emergency situations should be
documented in the SOP.
-
7/31/2019 3-2 Biosafety Risk Management
60/87
BSL4-Work Practices
c) Authorised persons should comply with the
instructions and all other applicable entry and exit
procedures in the manual and SOP
d) All personnel should be trained in the specific
working aspects of the containment laboratory,
including handling of the relevant pathogens, clean-
up of infectious spills and use of safety equipment.
-
7/31/2019 3-2 Biosafety Risk Management
61/87
BSL4-Work Practices
e) A risk assessment of the working environment
should be undertaken by management, taking into
consideration all matters influencing the safety of
personnel.
f) Personnel should enter and leave the facility
through the clothing change and shower rooms,
except in cases of emergency, for example fire or
explosion inside the containment laboratory,
personnel can use the air-locks to leave the
laboratory.
-
7/31/2019 3-2 Biosafety Risk Management
62/87
BSL4-Work Practices
g) Supplies, materials and specimens should only be
brought into the facility through the change and
shower rooms, the double-door pressure steam
steriliser, the fumigation chamber, the airlock or thedunk tank.
h) A primary container holding viable or intact
biological material should only be opened in the
maximum containment laboratory.
-
7/31/2019 3-2 Biosafety Risk Management
63/87
BSL4-Work Practices
i) No material should be removed from GM-BSL4
laboratory unless it has been autoclaved or
decontaminated..
j) RG 4 biological materials should be stored only within
the facility. If RG 4 biological materials are to be removed
from the maximum containment laboratory in a viable or
intact state, they should be transferred in a non-
breakable, sealed primary container, and then enclosed ina non-breakable, sealed secondary container, which isremoved from the facility through a disinfectant dunk
tank, fumigation chamber or an air-lock designed for this
purpose.
-
7/31/2019 3-2 Biosafety Risk Management
64/87
BSL4-Work Practices
k) All practices within the facility involving agents
assigned to RG 4 should be conducted in Class III
biological safety cabinets or alternatively Class II
biological safety cabinets used in conjunction withone-piece positive pressure personnel suits
ventilated by a life-support system.
l) Precautions should always be taken with any
contaminated sharp items including needles andsyringes, slides, pipettes, capillary tubes and
scalpels..
-
7/31/2019 3-2 Biosafety Risk Management
65/87
BSL4-Work Practices
m) A system should be set up for reporting accidents
and exposures to microorganisms and for the
medical surveillance of illnesses that are potentially
laboratory associated.
-
7/31/2019 3-2 Biosafety Risk Management
66/87
Scientists working in a BSL-4
-
7/31/2019 3-2 Biosafety Risk Management
67/87
BL4 Lab - Max
Containment
-
7/31/2019 3-2 Biosafety Risk Management
68/87
Containment Levelof Laboratories
CL1:-Ill just do it on the bench over there..
CL2:-OK, so Ill have to use the hood.
CL3:-Thats that room along the corridor that no-
one goes in? CL4:-Spacesuits?
-
7/31/2019 3-2 Biosafety Risk Management
69/87
BIOSAFETY CABINET
-
7/31/2019 3-2 Biosafety Risk Management
70/87
Biosafety Cabinet
Biological safety cabinets are the primary
means of containment in process support
laboratories and during early stages of culture
development Based on design and the protection afforded,
biological safety cabinets are designated as
Class I, II, and III
Must be properly maintained and regularlyserviced
Must be certified annually and when new,
moved, or repaired
-
7/31/2019 3-2 Biosafety Risk Management
71/87
Biosafety Cabinet
Must be used in conjunction with goodmicrobiological techniques
Provide protection for personnel, product, and
environment
The cabinets should be decontaminated withformaldehyde gas or an equivalent disinfectant
before testing when there have been used for
handling RG 2, 3 or 4 microorganisms.
Penetration of the decontaminants throughoutall the sections of the cabinets is essential.
-
7/31/2019 3-2 Biosafety Risk Management
72/87
BSC Class I
A Class I cabinet is a ventilated cabinet for
personnel protection.
Air flows inward, away from the operator.
The exhaust air from this cabinet filters through aHigh Efficiency Particulate Air (HEPA) filter.
-
7/31/2019 3-2 Biosafety Risk Management
73/87
This cabinet is used in three operational models:
i. with full-width open front
ii. with an installed front-closures panel (having
four 12-cm diameter openings) without gloves
iii. with an installed front-closure panel equippedwith arm-length rubber gloves.
The face velocity of the inward flow of air through
the full-width open front is 30 m per minute or
greater.
-
7/31/2019 3-2 Biosafety Risk Management
74/87
BSC Class I
-
7/31/2019 3-2 Biosafety Risk Management
75/87
BSC Class II
A Class II cabinet is a ventilated cabinet for
personnel and product protection.
It has an open front with inward airflow for
personnel protection and HEPA filtered massairflow for product protection.
The cabinet exhaust air is filtered through a HEPA
filter.
The face velocity of the inward flow of air through
the full-width open front is 30 m per minute or
greater.
l
-
7/31/2019 3-2 Biosafety Risk Management
76/87
BSC Class II
While HEPA filters are effective for trappingparticulates and infectious agents, these filters will
not capture volatile chemicals or gases
As general, no BSC suited for handling volatile
toxic substances
l ( )
-
7/31/2019 3-2 Biosafety Risk Management
77/87
BSC Class II (A & B)
SC Cl
-
7/31/2019 3-2 Biosafety Risk Management
78/87
BSC Class III
A Class III cabinet is a closed-front ventilatedcabinet of gas-tight construction, which providesthe highest level of personnel protection amongbiological safety cabinets.
The interior of the cabinet is protected fromcontaminants outside of the cabinet.
The cabinet is fitted with arm-length rubber glovesand is operated under a negative pressure of atleast 1.25 cm water gauge.
All air supply is filtered through HEPA filters.Exhaust air is filtered through two HEPA filtersbefore being discharged to the outsideenvironment.
BSC Cl III
-
7/31/2019 3-2 Biosafety Risk Management
79/87
BSC Class III
-
7/31/2019 3-2 Biosafety Risk Management
80/87
HEPA FILTER
-
7/31/2019 3-2 Biosafety Risk Management
81/87
Control of airborne particulates in indoorenvironments is critical to develop quality
products, protect employees from contact with
hazardous materials, or prevent health problems
from prolonged exposure to allergens
HEPA filters in biological safety cabinet
particle sizes
efficiency and penetration
filter standards and performance testing
-
7/31/2019 3-2 Biosafety Risk Management
82/87
HEPA filter are rated to remove particles down to0.3micrometer with efficiency of 99.97%
Filters are susceptible to shock-induced
mechanical damage
Biosafety cabinet must be certified after initialinstallation, after relocation, after repair and at
yearly interval
-
7/31/2019 3-2 Biosafety Risk Management
83/87
The certification test depend on the type of cabinet Downflow velocity and volume testing (I and II)
Inflow velocity test (I and II)
Negative pressure testing (II and III)
Air flow smoke pattern test (I and II) HEPA filter leak test (I-III)
Cabinet leak test (II and III)
Alarm and interlocks (III)
BSC SUMMARY
-
7/31/2019 3-2 Biosafety Risk Management
84/87
BSC SUMMARY
Biohazard
level
Protection provided Cabinet
classPersonnel Product Environme
ntBL1-3 Yes No Yes I
BL1-3 Yes Yes Yes II
BL4 Yes Yes Yes III
-
7/31/2019 3-2 Biosafety Risk Management
85/87
LAYOUT
-
7/31/2019 3-2 Biosafety Risk Management
86/87
The layout of the facility affects efficiency of operations
the potential for containment
prevention of cross-contamination
Contained, clean, and dirty areas should beidentified on the process flow sheets and the
building layout drawings
Movement of personnel, equipment, process
streams, and air across containment boundary
must assure integrity of containment
-
7/31/2019 3-2 Biosafety Risk Management
87/87
Flows must be unidirectional (clean to dirty areas)-should not cross
No back-tracking
The biohazard containment areas and the aseptic
product filling areas should be located in differentwings of the facility, with no sharing of common
hallways or direct access
Adequate space
No overcrowded